Chimerix to Report Third Quarter 2022 Financial Results and Provide an Operational Update on November 3, 2022
DURHAM, N.C., Oct. 27, 2022 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend lives of patients facing deadly diseases, today announced that it will host a live conference call and audio webcast on Thursday, November 3, 2022 at 8:30 a.m. ET to report financial results for the third quarter ended September 30, 2022, and to provide a business overview.
Related news for (CMRX)
- Chimerix Reports Fourth Quarter and Year End 2024 Financial Results
- 24/7 Market News Snapshot 05 March, 2025 – Chimerix, Inc. (NASDAQ:CMRX)
- Breaking News: MoBot’s Latest Update as of 03/05/25 08:00 AM
- Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
- Don’t Miss Out: MoBot’s Latest Stock Updates 03/05/25 07:00 AM
